LITTLE FALLS, N.J.,
July 1, 2014 /PRNewswire/ -- CANTEL
MEDICAL CORP. (NYSE:CMN), today announced that the company has
successfully completed the acquisition of PuriCore International
Limited., a wholly-owned subsidiary of PuriCore plc (LSE:
PURI). The transaction further enhances Cantel Medical's
global leadership of automated endoscope reprocessing and provides
the company with additional resources and capabilities to execute
on its broader international strategy. PuriCore International
Limited will be renamed Cantel Medical (UK) Limited and will be
reported as part of our Endoscopy segment.
PuriCore International Limited is a leading provider of
automated endoscope reprocessors, endoscope drying and storage
cabinets, chemistry and consumables in addition to comprehensive
maintenance and validation services in the United Kingdom.
With an employee base of approximately 120 individuals, including a
complete sales and service team and facilities in Stafford and Clevedon, England, the addition of PuriCore
International provides Cantel Medical comprehensive coverage of the
UK market.
"This acquisition is an exciting step in the execution of our
international strategy," said Jorgen
Hansen, President of Medivators and COO of Cantel
Medical. "The addition of the PuriCore endoscopy business to
Medivators will meaningfully strengthen our offering in automated
endoscope reprocessing while also enhancing our international
capabilities and competitiveness. We are excited to welcome
the entire PuriCore International workforce to the Cantel family,
and we look forward to working together toward delivering infection
prevention and control solutions to patients and customers
worldwide."
About Cantel Medical Corp.
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention and control products and services for patients,
caregivers, and other healthcare providers which improve outcomes,
enhance safety and help save lives. Our products include
specialized medical device reprocessing systems for endoscopy and
renal dialysis, advanced water purification equipment, sterilants,
disinfectants and cleaners, sterility assurance monitoring products
for hospitals and dental clinics, disposable infection control
products primarily for dental and GI endoscopy markets, dialysate
concentrates, hollow fiber membrane filtration and separation
products, and specialty packaging for infectious and biological
specimens. Additionally, we provide technical service for our
products. For further information, visit the Cantel website
at www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.